Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1Phase 1/2 1

Status

Terminated 4Completed 4Active not recruiting 2Unknown 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1Breast 1

Conditions

Breast Neoplasms 431Carcinoma, Non-Small-Cell Lung 372Neoplasms 324Prostatic Neoplasms 244Leukemia, Myeloid, Acute 230Multiple Myeloma 229Neoplasm Metastasis 215Melanoma 200Lung Neoplasms 178Leukemia 172Lymphoma 170Colorectal Neoplasms 157Pancreatic Neoplasms 151Lymphoma, Non-Hodgkin 150Recurrence 149Ovarian Neoplasms 143Leukemia, Lymphocytic, Chronic, B-Cell 134Precursor Cell Lymphoblastic Leukemia-Lymphoma 131Myelodysplastic Syndromes 121Carcinoma, Renal Cell 120Lymphoma, Large B-Cell, Diffuse 111Lymphoma, Follicular 108Brain Neoplasms 99Squamous Cell Carcinoma of Head and Neck 96Head and Neck Neoplasms 96Glioblastoma 92Urinary Bladder Neoplasms 88Carcinoma, Hepatocellular 80Hodgkin Disease 73Colonic Neoplasms 73

Interventions

ruxolitinib 1eltrombopag 1Doxorubicin 1Docetaxel 1Cytarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Has results × Pathologic Complete Response × Clear all
NCT01794572 2025-12-12

TOMMY

Institut Cancerologie de l'Ouest

Phase NA Terminated
13 enrolled 10 charts
Plasma cell

Pathologic Complete Response, Multiple Myeloma, Recurrence

NCT04934670 2024-08-27

2002

Xenikos

Phase 3 Terminated
12 enrolled 12 charts
Lymphoid

Pathologic Complete Response, Lymphoma, Follicular

NCT01656252 2020-11-03

PrE0901

PrECOG, LLC.

Phase 1/2 Terminated
15 enrolled 5 charts
Classical hematologyOther hematologic neoplasm

Jacobs syndrome, Pathologic Complete Response, Leukemia, Thrombocytopenia, Leukemia, Myeloid, Acute

NCT00636441 2015-12-11

Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast Cancer

Duke University

Phase 2 Terminated
56 enrolled 16 charts
Breast

Pathologic Complete Response, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡